Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
4.000
+0.130 (3.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $172.69 million as of December 20, 2024.
Market Cap
172.69M
Enterprise Value
-139.76M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $172.69M, a decrease of -80.77%. That is a compound annual growth rate of -85.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2024 | 167.07M | -81.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 181.18M |
| MediWound | 181.16M |
| Orchestra BioMed Holdings | 179.80M |
| Checkpoint Therapeutics | 179.22M |
| Alector | 175.30M |
| EUDA Health Holdings | 173.36M |
| BrainsWay | 173.14M |
| InfuSystem Holdings | 173.09M |